Back to Authors

Kim, T. M.

A5064765139 | I2802835388

Mayo Clinic

Seoul National University Hospital

Citations 3

242 | LONG‐TERM EFFICACY AND SURVIVAL OUTCOMES WITH ODRONEXTAMAB IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): 2‐YEAR FOLLOW‐UP FROM THE PHASE 2 ELM‐2 STUDY

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70094_242

Patient‐ versus clinician‐reported symptoms in the POLARIX study

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 414-416

10.1002/hon.3164_305

ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 121-122

10.1002/hon.3163_82